nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLC22A1—hematologic cancer	0.149	0.503	CbGaD
Nelfinavir—ABCG2—hematologic cancer	0.104	0.351	CbGaD
Nelfinavir—ABCB1—hematologic cancer	0.0432	0.146	CbGaD
Nelfinavir—SLCO1A2—Chlorambucil—hematologic cancer	0.0188	0.0375	CbGbCtD
Nelfinavir—ABCG2—Clofarabine—hematologic cancer	0.017	0.0339	CbGbCtD
Nelfinavir—SLC22A1—Cytarabine—hematologic cancer	0.0103	0.0207	CbGbCtD
Nelfinavir—CYP1A2—Anagrelide—hematologic cancer	0.0101	0.0202	CbGbCtD
Nelfinavir—ABCG2—Daunorubicin—hematologic cancer	0.00996	0.0199	CbGbCtD
Nelfinavir—CYP2B6—Thiotepa—hematologic cancer	0.0099	0.0198	CbGbCtD
Nelfinavir—SLC22A1—Cladribine—hematologic cancer	0.00976	0.0195	CbGbCtD
Nelfinavir—SLC22A1—Imatinib—hematologic cancer	0.00898	0.0179	CbGbCtD
Nelfinavir—ABCG2—Teniposide—hematologic cancer	0.00865	0.0173	CbGbCtD
Nelfinavir—ABCG2—Cladribine—hematologic cancer	0.00829	0.0166	CbGbCtD
Nelfinavir—ABCG2—Imatinib—hematologic cancer	0.00763	0.0152	CbGbCtD
Nelfinavir—SLCO1A2—Prednisolone—hematologic cancer	0.0071	0.0142	CbGbCtD
Nelfinavir—ABCG2—Nilotinib—hematologic cancer	0.00693	0.0139	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—hematologic cancer	0.0067	0.0134	CbGbCtD
Nelfinavir—CYP2C9—Bexarotene—hematologic cancer	0.00631	0.0126	CbGbCtD
Nelfinavir—ABCG2—Dasatinib—hematologic cancer	0.00613	0.0122	CbGbCtD
Nelfinavir—ABCB1—Lenalidomide—hematologic cancer	0.00612	0.0122	CbGbCtD
Nelfinavir—ABCG2—Mitoxantrone—hematologic cancer	0.00605	0.0121	CbGbCtD
Nelfinavir—SLCO1B1—Irinotecan—hematologic cancer	0.006	0.012	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0059	0.0118	CbGbCtD
Nelfinavir—CYP3A7—Ifosfamide—hematologic cancer	0.0059	0.0118	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00563	0.0113	CbGbCtD
Nelfinavir—CYP3A7—Imatinib—hematologic cancer	0.00563	0.0113	CbGbCtD
Nelfinavir—CYP2B6—Ifosfamide—hematologic cancer	0.00561	0.0112	CbGbCtD
Nelfinavir—CYP3A5—Daunorubicin—hematologic cancer	0.00552	0.011	CbGbCtD
Nelfinavir—CYP2D6—Lomustine—hematologic cancer	0.00536	0.0107	CbGbCtD
Nelfinavir—CYP1A2—Carmustine—hematologic cancer	0.00531	0.0106	CbGbCtD
Nelfinavir—CYP2C9—Idarubicin—hematologic cancer	0.00523	0.0105	CbGbCtD
Nelfinavir—CYP3A5—Thalidomide—hematologic cancer	0.00502	0.01	CbGbCtD
Nelfinavir—CYP2B6—Nilotinib—hematologic cancer	0.00487	0.00974	CbGbCtD
Nelfinavir—CYP3A5—Teniposide—hematologic cancer	0.00479	0.00958	CbGbCtD
Nelfinavir—CYP2D6—Idarubicin—hematologic cancer	0.00478	0.00956	CbGbCtD
Nelfinavir—ABCG2—Irinotecan—hematologic cancer	0.00476	0.00952	CbGbCtD
Nelfinavir—CYP2C19—Bortezomib—hematologic cancer	0.00465	0.0093	CbGbCtD
Nelfinavir—CYP1A2—Methoxsalen—hematologic cancer	0.00451	0.00902	CbGbCtD
Nelfinavir—CYP3A5—Ifosfamide—hematologic cancer	0.00442	0.00884	CbGbCtD
Nelfinavir—CYP1A2—Bortezomib—hematologic cancer	0.00429	0.00858	CbGbCtD
Nelfinavir—CYP3A5—Imatinib—hematologic cancer	0.00423	0.00845	CbGbCtD
Nelfinavir—SLCO1A2—Dexamethasone—hematologic cancer	0.00419	0.00837	CbGbCtD
Nelfinavir—ABCG2—Vincristine—hematologic cancer	0.00416	0.00832	CbGbCtD
Nelfinavir—CYP1A2—Daunorubicin—hematologic cancer	0.00411	0.00821	CbGbCtD
Nelfinavir—CYP2D6—Hydroxyurea—hematologic cancer	0.00407	0.00813	CbGbCtD
Nelfinavir—CYP2C19—Thalidomide—hematologic cancer	0.00405	0.0081	CbGbCtD
Nelfinavir—CYP1A2—Alitretinoin—hematologic cancer	0.00402	0.00804	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—hematologic cancer	0.00388	0.00776	CbGbCtD
Nelfinavir—CYP2C9—Bortezomib—hematologic cancer	0.00387	0.00773	CbGbCtD
Nelfinavir—CYP2C19—Teniposide—hematologic cancer	0.00387	0.00773	CbGbCtD
Nelfinavir—ABCG2—Etoposide—hematologic cancer	0.00382	0.00763	CbGbCtD
Nelfinavir—CYP1A2—Thalidomide—hematologic cancer	0.00374	0.00747	CbGbCtD
Nelfinavir—CYP3A4—Bexarotene—hematologic cancer	0.00367	0.00733	CbGbCtD
Nelfinavir—ABCB1—Daunorubicin—hematologic cancer	0.00359	0.00718	CbGbCtD
Nelfinavir—CYP2C19—Ifosfamide—hematologic cancer	0.00357	0.00713	CbGbCtD
Nelfinavir—CYP2D6—Bortezomib—hematologic cancer	0.00354	0.00707	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00352	0.00703	CbGbCtD
Nelfinavir—CYP3A7—Irinotecan—hematologic cancer	0.00352	0.00703	CbGbCtD
Nelfinavir—ABCB1—Alitretinoin—hematologic cancer	0.00352	0.00703	CbGbCtD
Nelfinavir—CYP3A4—Busulfan—hematologic cancer	0.00341	0.00682	CbGbCtD
Nelfinavir—CYP3A4—Lomustine—hematologic cancer	0.00341	0.00682	CbGbCtD
Nelfinavir—CYP2C19—Imatinib—hematologic cancer	0.00341	0.00681	CbGbCtD
Nelfinavir—CYP3A5—Dasatinib—hematologic cancer	0.00339	0.00678	CbGbCtD
Nelfinavir—CYP2C9—Thalidomide—hematologic cancer	0.00337	0.00674	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—hematologic cancer	0.00336	0.00672	CbGbCtD
Nelfinavir—CYP2B6—Irinotecan—hematologic cancer	0.00335	0.0067	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—hematologic cancer	0.00322	0.00643	CbGbCtD
Nelfinavir—CYP2C9—Teniposide—hematologic cancer	0.00321	0.00643	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—hematologic cancer	0.00317	0.00634	CbGbCtD
Nelfinavir—CYP1A2—Imatinib—hematologic cancer	0.00314	0.00629	CbGbCtD
Nelfinavir—ABCG2—Dexamethasone—hematologic cancer	0.00314	0.00627	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00308	0.00615	CbGbCtD
Nelfinavir—CYP3A7—Vincristine—hematologic cancer	0.00308	0.00615	CbGbCtD
Nelfinavir—CYP3A4—Thiotepa—hematologic cancer	0.00304	0.00608	CbGbCtD
Nelfinavir—CYP2C9—Ifosfamide—hematologic cancer	0.00297	0.00593	CbGbCtD
Nelfinavir—CYP2C9—Imatinib—hematologic cancer	0.00283	0.00566	CbGbCtD
Nelfinavir—ABCB1—Imatinib—hematologic cancer	0.00275	0.0055	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—hematologic cancer	0.00273	0.00546	CbGbCtD
Nelfinavir—CYP3A5—Irinotecan—hematologic cancer	0.00264	0.00528	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—hematologic cancer	0.0026	0.0052	CbGbCtD
Nelfinavir—CYP2D6—Imatinib—hematologic cancer	0.00259	0.00518	CbGbCtD
Nelfinavir—CYP2C9—Nilotinib—hematologic cancer	0.00257	0.00515	CbGbCtD
Nelfinavir—CYP1A2—Dasatinib—hematologic cancer	0.00253	0.00505	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—hematologic cancer	0.00252	0.00504	CbGbCtD
Nelfinavir—ABCB1—Nilotinib—hematologic cancer	0.0025	0.005	CbGbCtD
Nelfinavir—ABCB1—Vinorelbine—hematologic cancer	0.00248	0.00495	CbGbCtD
Nelfinavir—CYP3A4—Methoxsalen—hematologic cancer	0.00236	0.00473	CbGbCtD
Nelfinavir—CYP2D6—Nilotinib—hematologic cancer	0.00235	0.00471	CbGbCtD
Nelfinavir—CYP2D6—Vinorelbine—hematologic cancer	0.00233	0.00467	CbGbCtD
Nelfinavir—CYP3A7—Dexamethasone—hematologic cancer	0.00232	0.00463	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00232	0.00463	CbGbCtD
Nelfinavir—CYP3A5—Vincristine—hematologic cancer	0.00231	0.00461	CbGbCtD
Nelfinavir—CYP3A4—Bortezomib—hematologic cancer	0.00225	0.0045	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—hematologic cancer	0.00225	0.00449	CbGbCtD
Nelfinavir—ABCB1—Dasatinib—hematologic cancer	0.00221	0.00442	CbGbCtD
Nelfinavir—CYP2B6—Dexamethasone—hematologic cancer	0.00221	0.00441	CbGbCtD
Nelfinavir—ABCB1—Mitoxantrone—hematologic cancer	0.00218	0.00436	CbGbCtD
Nelfinavir—CYP3A4—Daunorubicin—hematologic cancer	0.00215	0.0043	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—hematologic cancer	0.00211	0.00423	CbGbCtD
Nelfinavir—ABCB1—Betamethasone—hematologic cancer	0.00194	0.00389	CbGbCtD
Nelfinavir—ABCB1—Gemcitabine—hematologic cancer	0.00193	0.00385	CbGbCtD
Nelfinavir—ABCB1—Prednisolone—hematologic cancer	0.00192	0.00384	CbGbCtD
Nelfinavir—CYP3A4—Cytarabine—hematologic cancer	0.0019	0.00379	CbGbCtD
Nelfinavir—CYP3A4—Teniposide—hematologic cancer	0.00187	0.00374	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—hematologic cancer	0.00183	0.00366	CbGbCtD
Nelfinavir—ABCB1—Prednisone—hematologic cancer	0.00181	0.00362	CbGbCtD
Nelfinavir—CYP3A5—Dexamethasone—hematologic cancer	0.00174	0.00347	CbGbCtD
Nelfinavir—CYP3A4—Ifosfamide—hematologic cancer	0.00172	0.00345	CbGbCtD
Nelfinavir—ABCB1—Irinotecan—hematologic cancer	0.00172	0.00343	CbGbCtD
Nelfinavir—CYP3A4—Imatinib—hematologic cancer	0.00165	0.00329	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—hematologic cancer	0.00157	0.00315	CbGbCtD
Nelfinavir—CYP3A4—Ruxolitinib—hematologic cancer	0.00155	0.0031	CbGbCtD
Nelfinavir—ABCB1—Vinblastine—hematologic cancer	0.00153	0.00305	CbGbCtD
Nelfinavir—ABCB1—Vincristine—hematologic cancer	0.0015	0.003	CbGbCtD
Nelfinavir—CYP3A4—Nilotinib—hematologic cancer	0.0015	0.00299	CbGbCtD
Nelfinavir—CYP3A4—Vinorelbine—hematologic cancer	0.00148	0.00297	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—hematologic cancer	0.00144	0.00288	CbGbCtD
Nelfinavir—CYP2D6—Vinblastine—hematologic cancer	0.00144	0.00288	CbGbCtD
Nelfinavir—CYP2C19—Dexamethasone—hematologic cancer	0.0014	0.0028	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—hematologic cancer	0.0014	0.0028	CbGbCtD
Nelfinavir—ABCB1—Etoposide—hematologic cancer	0.00138	0.00275	CbGbCtD
Nelfinavir—CYP3A4—Triamcinolone—hematologic cancer	0.00136	0.00271	CbGbCtD
Nelfinavir—CYP3A4—Dasatinib—hematologic cancer	0.00132	0.00265	CbGbCtD
Nelfinavir—CYP3A4—Mitoxantrone—hematologic cancer	0.00131	0.00261	CbGbCtD
Nelfinavir—CYP2C9—Dexamethasone—hematologic cancer	0.00117	0.00233	CbGbCtD
Nelfinavir—CYP3A4—Betamethasone—hematologic cancer	0.00116	0.00233	CbGbCtD
Nelfinavir—CYP3A4—Prednisolone—hematologic cancer	0.00115	0.0023	CbGbCtD
Nelfinavir—ABCB1—Dexamethasone—hematologic cancer	0.00113	0.00226	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—hematologic cancer	0.00109	0.00217	CbGbCtD
Nelfinavir—CYP2D6—Dexamethasone—hematologic cancer	0.00107	0.00213	CbGbCtD
Nelfinavir—CYP3A4—Irinotecan—hematologic cancer	0.00103	0.00206	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—hematologic cancer	0.000938	0.00188	CbGbCtD
Nelfinavir—CYP3A4—Vinblastine—hematologic cancer	0.000915	0.00183	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—hematologic cancer	0.000909	0.00182	CbGbCtD
Nelfinavir—CYP3A4—Vincristine—hematologic cancer	0.000899	0.0018	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—hematologic cancer	0.000884	0.00177	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—hematologic cancer	0.000824	0.00165	CbGbCtD
Nelfinavir—CYP3A4—Dexamethasone—hematologic cancer	0.000678	0.00135	CbGbCtD
Nelfinavir—Indinavir—SLC22A1—hematologic cancer	0.000582	0.333	CrCbGaD
Nelfinavir—CYP3A4—Doxorubicin—hematologic cancer	0.000562	0.00112	CbGbCtD
Nelfinavir—SLCO1B1—hematopoietic system—hematologic cancer	0.000467	0.0698	CbGeAlD
Nelfinavir—Saquinavir—SLC22A1—hematologic cancer	0.000434	0.249	CrCbGaD
Nelfinavir—SLCO1A2—hematopoietic system—hematologic cancer	0.00038	0.0568	CbGeAlD
Nelfinavir—SLCO1B1—blood—hematologic cancer	0.00031	0.0462	CbGeAlD
Nelfinavir—CYP2C19—hematopoietic system—hematologic cancer	0.000305	0.0455	CbGeAlD
Nelfinavir—Saquinavir—ABCG2—hematologic cancer	0.000303	0.174	CrCbGaD
Nelfinavir—SLC22A1—blood—hematologic cancer	0.000262	0.0391	CbGeAlD
Nelfinavir—CYP1A2—hematopoietic system—hematologic cancer	0.000249	0.0371	CbGeAlD
Nelfinavir—CYP3A5—hematopoietic system—hematologic cancer	0.00024	0.0358	CbGeAlD
Nelfinavir—CYP2B6—hematopoietic system—hematologic cancer	0.000238	0.0356	CbGeAlD
Nelfinavir—CYP2C9—hematopoietic system—hematologic cancer	0.000236	0.0352	CbGeAlD
Nelfinavir—SLCO1A2—lung—hematologic cancer	0.000221	0.033	CbGeAlD
Nelfinavir—SLCO1A2—testis—hematologic cancer	0.000208	0.0311	CbGeAlD
Nelfinavir—CYP2C19—blood—hematologic cancer	0.000202	0.0301	CbGeAlD
Nelfinavir—CYP2B6—gonad—hematologic cancer	0.000181	0.0271	CbGeAlD
Nelfinavir—CYP3A4—hematopoietic system—hematologic cancer	0.00018	0.0269	CbGeAlD
Nelfinavir—CYP2D6—hematopoietic system—hematologic cancer	0.000177	0.0264	CbGeAlD
Nelfinavir—ABCG2—blood—hematologic cancer	0.000171	0.0256	CbGeAlD
Nelfinavir—Indinavir—ABCB1—hematologic cancer	0.000169	0.0968	CrCbGaD
Nelfinavir—ABCG2—bone marrow—hematologic cancer	0.000166	0.0247	CbGeAlD
Nelfinavir—CYP1A2—blood—hematologic cancer	0.000165	0.0246	CbGeAlD
Nelfinavir—CYP3A5—blood—hematologic cancer	0.000159	0.0237	CbGeAlD
Nelfinavir—CYP2B6—blood—hematologic cancer	0.000158	0.0236	CbGeAlD
Nelfinavir—CYP2C9—blood—hematologic cancer	0.000156	0.0234	CbGeAlD
Nelfinavir—ABCG2—lung—hematologic cancer	0.00015	0.0224	CbGeAlD
Nelfinavir—CYP1A2—lung—hematologic cancer	0.000144	0.0216	CbGeAlD
Nelfinavir—ABCG2—testis—hematologic cancer	0.000142	0.0211	CbGeAlD
Nelfinavir—CYP3A5—lung—hematologic cancer	0.000139	0.0208	CbGeAlD
Nelfinavir—CYP2B6—lung—hematologic cancer	0.000138	0.0207	CbGeAlD
Nelfinavir—Saquinavir—ALB—hematologic cancer	0.000132	0.0757	CrCbGaD
Nelfinavir—CYP2B6—testis—hematologic cancer	0.000131	0.0195	CbGeAlD
Nelfinavir—ABCB1—hematopoietic system—hematologic cancer	0.000127	0.019	CbGeAlD
Nelfinavir—Saquinavir—ABCB1—hematologic cancer	0.000126	0.0723	CrCbGaD
Nelfinavir—CYP3A4—blood—hematologic cancer	0.000119	0.0178	CbGeAlD
Nelfinavir—CYP2D6—blood—hematologic cancer	0.000117	0.0175	CbGeAlD
Nelfinavir—ABCG2—lymph node—hematologic cancer	0.000103	0.0153	CbGeAlD
Nelfinavir—CYP2D6—testis—hematologic cancer	9.71e-05	0.0145	CbGeAlD
Nelfinavir—ABCB1—gonad—hematologic cancer	9.69e-05	0.0145	CbGeAlD
Nelfinavir—ABCB1—blood—hematologic cancer	8.44e-05	0.0126	CbGeAlD
Nelfinavir—ABCB1—bone marrow—hematologic cancer	8.17e-05	0.0122	CbGeAlD
Nelfinavir—ABCB1—lung—hematologic cancer	7.4e-05	0.011	CbGeAlD
Nelfinavir—ABCB1—testis—hematologic cancer	6.98e-05	0.0104	CbGeAlD
Nelfinavir—ABCB1—lymph node—hematologic cancer	5.06e-05	0.00756	CbGeAlD
Nelfinavir—Erythema multiforme—Epirubicin—hematologic cancer	2.09e-05	0.000134	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—hematologic cancer	2.09e-05	0.000134	CcSEcCtD
Nelfinavir—Vomiting—Gemcitabine—hematologic cancer	2.09e-05	0.000134	CcSEcCtD
Nelfinavir—Insomnia—Dexamethasone—hematologic cancer	2.09e-05	0.000134	CcSEcCtD
Nelfinavir—Insomnia—Betamethasone—hematologic cancer	2.09e-05	0.000134	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.08e-05	0.000133	CcSEcCtD
Nelfinavir—Paraesthesia—Betamethasone—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Nelfinavir—Paraesthesia—Dexamethasone—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Nelfinavir—Rash—Gemcitabine—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Nelfinavir—Dermatitis—Gemcitabine—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—hematologic cancer	2.07e-05	0.000132	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—hematologic cancer	2.07e-05	0.000132	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Nelfinavir—Headache—Gemcitabine—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Nelfinavir—Nausea—Vincristine—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisolone—hematologic cancer	2.04e-05	0.000131	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—hematologic cancer	2.03e-05	0.00013	CcSEcCtD
Nelfinavir—Dyspepsia—Dexamethasone—hematologic cancer	2.03e-05	0.00013	CcSEcCtD
Nelfinavir—Dyspepsia—Betamethasone—hematologic cancer	2.03e-05	0.00013	CcSEcCtD
Nelfinavir—Urticaria—Triamcinolone—hematologic cancer	2.02e-05	0.000129	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Body temperature increased—Triamcinolone—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Oedema—Prednisone—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Decreased appetite—Dexamethasone—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Decreased appetite—Betamethasone—hematologic cancer	2.01e-05	0.000129	CcSEcCtD
Nelfinavir—Nausea—Mitoxantrone—hematologic cancer	2e-05	0.000128	CcSEcCtD
Nelfinavir—Nausea—Irinotecan—hematologic cancer	2e-05	0.000128	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—hematologic cancer	2e-05	0.000128	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.99e-05	0.000128	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.99e-05	0.000128	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—hematologic cancer	1.99e-05	0.000128	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—hematologic cancer	1.98e-05	0.000127	CcSEcCtD
Nelfinavir—Pain—Dexamethasone—hematologic cancer	1.97e-05	0.000126	CcSEcCtD
Nelfinavir—Pain—Betamethasone—hematologic cancer	1.97e-05	0.000126	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—hematologic cancer	1.95e-05	0.000125	CcSEcCtD
Nelfinavir—Nausea—Gemcitabine—hematologic cancer	1.95e-05	0.000125	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—hematologic cancer	1.95e-05	0.000125	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—hematologic cancer	1.94e-05	0.000124	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—hematologic cancer	1.94e-05	0.000124	CcSEcCtD
Nelfinavir—Rash—Cisplatin—hematologic cancer	1.93e-05	0.000124	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—hematologic cancer	1.93e-05	0.000124	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—hematologic cancer	1.93e-05	0.000123	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—hematologic cancer	1.93e-05	0.000123	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—hematologic cancer	1.92e-05	0.000123	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—hematologic cancer	1.92e-05	0.000123	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—hematologic cancer	1.91e-05	0.000123	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—hematologic cancer	1.91e-05	0.000122	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Nelfinavir—Feeling abnormal—Betamethasone—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Nelfinavir—Feeling abnormal—Dexamethasone—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.89e-05	0.000121	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.89e-05	0.000121	CcSEcCtD
Nelfinavir—Hypersensitivity—Triamcinolone—hematologic cancer	1.87e-05	0.00012	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—hematologic cancer	1.86e-05	0.000119	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—hematologic cancer	1.86e-05	0.000119	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—hematologic cancer	1.86e-05	0.000119	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—hematologic cancer	1.85e-05	0.000119	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—hematologic cancer	1.85e-05	0.000119	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000118	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—hematologic cancer	1.84e-05	0.000118	CcSEcCtD
Nelfinavir—Urticaria—Betamethasone—hematologic cancer	1.83e-05	0.000117	CcSEcCtD
Nelfinavir—Urticaria—Dexamethasone—hematologic cancer	1.83e-05	0.000117	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.83e-05	0.000117	CcSEcCtD
Nelfinavir—Dizziness—Prednisolone—hematologic cancer	1.83e-05	0.000117	CcSEcCtD
Nelfinavir—Asthenia—Triamcinolone—hematologic cancer	1.82e-05	0.000117	CcSEcCtD
Nelfinavir—Abdominal pain—Dexamethasone—hematologic cancer	1.82e-05	0.000117	CcSEcCtD
Nelfinavir—Body temperature increased—Dexamethasone—hematologic cancer	1.82e-05	0.000117	CcSEcCtD
Nelfinavir—Abdominal pain—Betamethasone—hematologic cancer	1.82e-05	0.000117	CcSEcCtD
Nelfinavir—Body temperature increased—Betamethasone—hematologic cancer	1.82e-05	0.000117	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—hematologic cancer	1.82e-05	0.000116	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—hematologic cancer	1.82e-05	0.000116	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—hematologic cancer	1.8e-05	0.000116	CcSEcCtD
Nelfinavir—Pruritus—Triamcinolone—hematologic cancer	1.8e-05	0.000115	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—hematologic cancer	1.79e-05	0.000114	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—hematologic cancer	1.77e-05	0.000113	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—hematologic cancer	1.77e-05	0.000113	CcSEcCtD
Nelfinavir—Rash—Etoposide—hematologic cancer	1.77e-05	0.000113	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—hematologic cancer	1.77e-05	0.000113	CcSEcCtD
Nelfinavir—Headache—Etoposide—hematologic cancer	1.76e-05	0.000113	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—hematologic cancer	1.76e-05	0.000113	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—hematologic cancer	1.75e-05	0.000112	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—hematologic cancer	1.75e-05	0.000112	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—hematologic cancer	1.75e-05	0.000112	CcSEcCtD
Nelfinavir—Rash—Prednisolone—hematologic cancer	1.74e-05	0.000112	CcSEcCtD
Nelfinavir—Dermatitis—Prednisolone—hematologic cancer	1.74e-05	0.000112	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Nelfinavir—Headache—Prednisolone—hematologic cancer	1.73e-05	0.000111	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—hematologic cancer	1.73e-05	0.000111	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—hematologic cancer	1.72e-05	0.00011	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—hematologic cancer	1.72e-05	0.00011	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—hematologic cancer	1.71e-05	0.00011	CcSEcCtD
Nelfinavir—Dizziness—Triamcinolone—hematologic cancer	1.68e-05	0.000108	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—hematologic cancer	1.67e-05	0.000107	CcSEcCtD
Nelfinavir—Nausea—Etoposide—hematologic cancer	1.67e-05	0.000107	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Nelfinavir—Asthenia—Betamethasone—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Nelfinavir—Asthenia—Dexamethasone—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—hematologic cancer	1.65e-05	0.000106	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—hematologic cancer	1.65e-05	0.000106	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Nausea—Prednisolone—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—hematologic cancer	1.63e-05	0.000105	CcSEcCtD
Nelfinavir—Pruritus—Betamethasone—hematologic cancer	1.63e-05	0.000105	CcSEcCtD
Nelfinavir—Pruritus—Dexamethasone—hematologic cancer	1.63e-05	0.000105	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—hematologic cancer	1.63e-05	0.000105	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.63e-05	0.000104	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—hematologic cancer	1.62e-05	0.000104	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—hematologic cancer	1.62e-05	0.000104	CcSEcCtD
Nelfinavir—Vomiting—Triamcinolone—hematologic cancer	1.62e-05	0.000104	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—hematologic cancer	1.61e-05	0.000103	CcSEcCtD
Nelfinavir—Rash—Triamcinolone—hematologic cancer	1.6e-05	0.000103	CcSEcCtD
Nelfinavir—Dermatitis—Triamcinolone—hematologic cancer	1.6e-05	0.000103	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—hematologic cancer	1.6e-05	0.000103	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—hematologic cancer	1.6e-05	0.000102	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—hematologic cancer	1.59e-05	0.000102	CcSEcCtD
Nelfinavir—Headache—Triamcinolone—hematologic cancer	1.59e-05	0.000102	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—hematologic cancer	1.59e-05	0.000102	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—hematologic cancer	1.59e-05	0.000102	CcSEcCtD
Nelfinavir—Diarrhoea—Dexamethasone—hematologic cancer	1.58e-05	0.000101	CcSEcCtD
Nelfinavir—Diarrhoea—Betamethasone—hematologic cancer	1.58e-05	0.000101	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—hematologic cancer	1.57e-05	0.000101	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—hematologic cancer	1.54e-05	9.89e-05	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—hematologic cancer	1.54e-05	9.86e-05	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.53e-05	9.8e-05	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—hematologic cancer	1.53e-05	9.78e-05	CcSEcCtD
Nelfinavir—Dizziness—Betamethasone—hematologic cancer	1.53e-05	9.78e-05	CcSEcCtD
Nelfinavir—Dizziness—Dexamethasone—hematologic cancer	1.53e-05	9.78e-05	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—hematologic cancer	1.52e-05	9.74e-05	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—hematologic cancer	1.52e-05	9.73e-05	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—hematologic cancer	1.52e-05	9.72e-05	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—hematologic cancer	1.52e-05	9.72e-05	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—hematologic cancer	1.51e-05	9.69e-05	CcSEcCtD
Nelfinavir—Nausea—Triamcinolone—hematologic cancer	1.51e-05	9.68e-05	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—hematologic cancer	1.51e-05	9.66e-05	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.51e-05	9.65e-05	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—hematologic cancer	1.5e-05	9.6e-05	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—hematologic cancer	1.5e-05	9.6e-05	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—hematologic cancer	1.5e-05	9.59e-05	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—hematologic cancer	1.49e-05	9.57e-05	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—hematologic cancer	1.48e-05	9.49e-05	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—hematologic cancer	1.48e-05	9.47e-05	CcSEcCtD
Nelfinavir—Vomiting—Betamethasone—hematologic cancer	1.47e-05	9.4e-05	CcSEcCtD
Nelfinavir—Vomiting—Dexamethasone—hematologic cancer	1.47e-05	9.4e-05	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—hematologic cancer	1.46e-05	9.35e-05	CcSEcCtD
Nelfinavir—Rash—Betamethasone—hematologic cancer	1.45e-05	9.32e-05	CcSEcCtD
Nelfinavir—Rash—Dexamethasone—hematologic cancer	1.45e-05	9.32e-05	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—hematologic cancer	1.45e-05	9.32e-05	CcSEcCtD
Nelfinavir—Dermatitis—Dexamethasone—hematologic cancer	1.45e-05	9.31e-05	CcSEcCtD
Nelfinavir—Dermatitis—Betamethasone—hematologic cancer	1.45e-05	9.31e-05	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.45e-05	9.29e-05	CcSEcCtD
Nelfinavir—Headache—Dexamethasone—hematologic cancer	1.45e-05	9.26e-05	CcSEcCtD
Nelfinavir—Headache—Betamethasone—hematologic cancer	1.45e-05	9.26e-05	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—hematologic cancer	1.44e-05	9.24e-05	CcSEcCtD
Nelfinavir—Pain—Methotrexate—hematologic cancer	1.44e-05	9.2e-05	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.43e-05	9.18e-05	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—hematologic cancer	1.42e-05	9.12e-05	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—hematologic cancer	1.42e-05	9.11e-05	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—hematologic cancer	1.42e-05	9.11e-05	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—hematologic cancer	1.41e-05	9.05e-05	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—hematologic cancer	1.41e-05	9.04e-05	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.41e-05	9.01e-05	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—hematologic cancer	1.4e-05	8.98e-05	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—hematologic cancer	1.4e-05	8.95e-05	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—hematologic cancer	1.39e-05	8.88e-05	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—hematologic cancer	1.38e-05	8.87e-05	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—hematologic cancer	1.38e-05	8.86e-05	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—hematologic cancer	1.37e-05	8.81e-05	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.37e-05	8.8e-05	CcSEcCtD
Nelfinavir—Nausea—Dexamethasone—hematologic cancer	1.37e-05	8.78e-05	CcSEcCtD
Nelfinavir—Nausea—Betamethasone—hematologic cancer	1.37e-05	8.78e-05	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—hematologic cancer	1.37e-05	8.75e-05	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.36e-05	8.69e-05	CcSEcCtD
Nelfinavir—Pain—Epirubicin—hematologic cancer	1.34e-05	8.61e-05	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—hematologic cancer	1.33e-05	8.55e-05	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—hematologic cancer	1.33e-05	8.51e-05	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—hematologic cancer	1.33e-05	8.51e-05	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—hematologic cancer	1.33e-05	8.51e-05	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.32e-05	8.49e-05	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—hematologic cancer	1.32e-05	8.43e-05	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—hematologic cancer	1.31e-05	8.37e-05	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—hematologic cancer	1.3e-05	8.31e-05	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—hematologic cancer	1.29e-05	8.3e-05	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—hematologic cancer	1.29e-05	8.28e-05	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—hematologic cancer	1.28e-05	8.23e-05	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—hematologic cancer	1.28e-05	8.2e-05	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—hematologic cancer	1.28e-05	8.19e-05	CcSEcCtD
Nelfinavir—Rash—Prednisone—hematologic cancer	1.27e-05	8.12e-05	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—hematologic cancer	1.27e-05	8.11e-05	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—hematologic cancer	1.26e-05	8.1e-05	CcSEcCtD
Nelfinavir—Headache—Prednisone—hematologic cancer	1.26e-05	8.07e-05	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.26e-05	8.04e-05	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—hematologic cancer	1.25e-05	8e-05	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—hematologic cancer	1.24e-05	7.97e-05	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—hematologic cancer	1.24e-05	7.96e-05	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—hematologic cancer	1.24e-05	7.96e-05	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—hematologic cancer	1.24e-05	7.93e-05	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—hematologic cancer	1.2e-05	7.72e-05	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—hematologic cancer	1.2e-05	7.68e-05	CcSEcCtD
Nelfinavir—Nausea—Prednisone—hematologic cancer	1.19e-05	7.65e-05	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.19e-05	7.62e-05	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—hematologic cancer	1.19e-05	7.61e-05	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—hematologic cancer	1.16e-05	7.42e-05	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—hematologic cancer	1.16e-05	7.4e-05	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—hematologic cancer	1.15e-05	7.37e-05	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—hematologic cancer	1.15e-05	7.37e-05	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—hematologic cancer	1.15e-05	7.36e-05	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—hematologic cancer	1.13e-05	7.23e-05	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—hematologic cancer	1.11e-05	7.12e-05	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—hematologic cancer	1.11e-05	7.12e-05	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—hematologic cancer	1.08e-05	6.89e-05	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—hematologic cancer	1.07e-05	6.87e-05	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—hematologic cancer	1.07e-05	6.84e-05	CcSEcCtD
Nelfinavir—Rash—Methotrexate—hematologic cancer	1.06e-05	6.79e-05	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—hematologic cancer	1.06e-05	6.78e-05	CcSEcCtD
Nelfinavir—Headache—Methotrexate—hematologic cancer	1.05e-05	6.74e-05	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—hematologic cancer	1.04e-05	6.69e-05	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—hematologic cancer	1.04e-05	6.66e-05	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—hematologic cancer	1.03e-05	6.59e-05	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—hematologic cancer	9.99e-06	6.4e-05	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—hematologic cancer	9.97e-06	6.39e-05	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—hematologic cancer	9.95e-06	6.38e-05	CcSEcCtD
Nelfinavir—Rash—Epirubicin—hematologic cancer	9.91e-06	6.35e-05	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—hematologic cancer	9.9e-06	6.34e-05	CcSEcCtD
Nelfinavir—Headache—Epirubicin—hematologic cancer	9.84e-06	6.31e-05	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—hematologic cancer	9.61e-06	6.16e-05	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—hematologic cancer	9.33e-06	5.98e-05	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—hematologic cancer	9.24e-06	5.92e-05	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—hematologic cancer	9.17e-06	5.88e-05	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—hematologic cancer	9.16e-06	5.87e-05	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—hematologic cancer	9.11e-06	5.84e-05	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—hematologic cancer	8.64e-06	5.53e-05	CcSEcCtD
Nelfinavir—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.99e-06	7.51e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTP1—hematologic cancer	2.98e-06	7.5e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.97e-06	7.47e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—IDH2—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMMR—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTT1—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SDC1—hematologic cancer	2.92e-06	7.35e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.92e-06	7.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTP1—hematologic cancer	2.91e-06	7.33e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.91e-06	7.32e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	2.91e-06	7.32e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SDC1—hematologic cancer	2.9e-06	7.28e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.87e-06	7.2e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ABCB1—hematologic cancer	2.82e-06	7.1e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NUP98—hematologic cancer	2.82e-06	7.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.79e-06	7.01e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.78e-06	6.99e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.78e-06	6.99e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CG—hematologic cancer	2.78e-06	6.98e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.77e-06	6.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ABCB1—hematologic cancer	2.76e-06	6.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CG—hematologic cancer	2.75e-06	6.92e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTM1—hematologic cancer	2.74e-06	6.89e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NCOR1—hematologic cancer	2.74e-06	6.89e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.74e-06	6.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.74e-06	6.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.73e-06	6.87e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NUP214—hematologic cancer	2.72e-06	6.83e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ACP5—hematologic cancer	2.71e-06	6.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CA9—hematologic cancer	2.71e-06	6.82e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NQO1—hematologic cancer	2.7e-06	6.79e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CD44—hematologic cancer	2.7e-06	6.79e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.69e-06	6.76e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.69e-06	6.75e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.68e-06	6.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.68e-06	6.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.68e-06	6.73e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTR—hematologic cancer	2.66e-06	6.69e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.66e-06	6.69e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.65e-06	6.65e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CD44—hematologic cancer	2.64e-06	6.63e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NQO1—hematologic cancer	2.64e-06	6.63e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.64e-06	6.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.61e-06	6.57e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO2—hematologic cancer	2.61e-06	6.56e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—hematologic cancer	2.6e-06	6.54e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CREBBP—hematologic cancer	2.57e-06	6.47e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.56e-06	6.44e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYCS—hematologic cancer	2.56e-06	6.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CREBBP—hematologic cancer	2.55e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—IDH1—hematologic cancer	2.55e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.53e-06	6.37e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TXN—hematologic cancer	2.52e-06	6.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.52e-06	6.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.52e-06	6.34e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYCS—hematologic cancer	2.49e-06	6.27e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.49e-06	6.27e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.49e-06	6.26e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NQO1—hematologic cancer	2.48e-06	6.25e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CD44—hematologic cancer	2.48e-06	6.25e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.48e-06	6.23e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SDC1—hematologic cancer	2.48e-06	6.22e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.47e-06	6.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CD44—hematologic cancer	2.46e-06	6.19e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NQO1—hematologic cancer	2.46e-06	6.19e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.44e-06	6.13e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.42e-06	6.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.42e-06	6.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—hematologic cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—hematologic cancer	2.39e-06	6e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.37e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.37e-06	5.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.37e-06	5.95e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.36e-06	5.94e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYCS—hematologic cancer	2.35e-06	5.91e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.34e-06	5.87e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.33e-06	5.87e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYCS—hematologic cancer	2.33e-06	5.86e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.32e-06	5.83e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.32e-06	5.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.31e-06	5.8e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.31e-06	5.8e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.3e-06	5.79e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.3e-06	5.77e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.29e-06	5.75e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.28e-06	5.74e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.25e-06	5.66e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.25e-06	5.66e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.25e-06	5.65e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.23e-06	5.61e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—hematologic cancer	2.22e-06	5.59e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—hematologic cancer	2.21e-06	5.56e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—hematologic cancer	2.2e-06	5.53e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.18e-06	5.48e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NUP98—hematologic cancer	2.18e-06	5.47e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.13e-06	5.36e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.13e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.13e-06	5.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.11e-06	5.31e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.11e-06	5.31e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.11e-06	5.3e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NQO1—hematologic cancer	2.1e-06	5.29e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CD44—hematologic cancer	2.1e-06	5.29e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NUP214—hematologic cancer	2.1e-06	5.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.08e-06	5.24e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.06e-06	5.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.05e-06	5.17e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTR—hematologic cancer	2.05e-06	5.17e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.05e-06	5.16e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.03e-06	5.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NCOR1—hematologic cancer	2.02e-06	5.08e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—hematologic cancer	2.02e-06	5.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO2—hematologic cancer	2.02e-06	5.07e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYCS—hematologic cancer	1.99e-06	5.01e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.99e-06	5e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.99e-06	5e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.98e-06	4.99e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.98e-06	4.98e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.96e-06	4.93e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.96e-06	4.93e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.95e-06	4.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.94e-06	4.89e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SDC1—hematologic cancer	1.91e-06	4.8e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.9e-06	4.79e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.9e-06	4.79e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—hematologic cancer	1.89e-06	4.76e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.89e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.89e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.89e-06	4.74e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.84e-06	4.64e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—hematologic cancer	1.84e-06	4.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.83e-06	4.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—hematologic cancer	1.82e-06	4.58e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.79e-06	4.5e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—hematologic cancer	1.79e-06	4.49e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.78e-06	4.48e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—hematologic cancer	1.77e-06	4.44e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.76e-06	4.41e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—hematologic cancer	1.75e-06	4.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.75e-06	4.39e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—hematologic cancer	1.74e-06	4.37e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—hematologic cancer	1.73e-06	4.34e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.7e-06	4.27e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—hematologic cancer	1.7e-06	4.26e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.69e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.68e-06	4.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.67e-06	4.19e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.66e-06	4.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.65e-06	4.15e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.64e-06	4.12e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CD44—hematologic cancer	1.62e-06	4.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NQO1—hematologic cancer	1.62e-06	4.08e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—hematologic cancer	1.62e-06	4.06e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.61e-06	4.06e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.61e-06	4.06e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.61e-06	4.05e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.56e-06	3.92e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.54e-06	3.87e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYCS—hematologic cancer	1.54e-06	3.86e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.53e-06	3.84e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.52e-06	3.83e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.5e-06	3.77e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.47e-06	3.7e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.43e-06	3.58e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.43e-06	3.58e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.41e-06	3.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.4e-06	3.52e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.4e-06	3.52e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CREBBP—hematologic cancer	1.39e-06	3.5e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.35e-06	3.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.35e-06	3.4e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—hematologic cancer	1.35e-06	3.39e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.34e-06	3.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—hematologic cancer	1.33e-06	3.35e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.32e-06	3.32e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—hematologic cancer	1.32e-06	3.31e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.31e-06	3.3e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—hematologic cancer	1.3e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.3e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.3e-06	3.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.28e-06	3.23e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—hematologic cancer	1.28e-06	3.23e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.28e-06	3.22e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.28e-06	3.21e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.26e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—hematologic cancer	1.26e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.25e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.25e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.25e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.24e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.23e-06	3.1e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—hematologic cancer	1.23e-06	3.09e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—hematologic cancer	1.22e-06	3.06e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.2e-06	3.01e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.2e-06	3.01e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.18e-06	2.96e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.17e-06	2.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.16e-06	2.93e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.15e-06	2.89e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.14e-06	2.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.11e-06	2.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.1e-06	2.77e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.08e-06	2.72e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.07e-06	2.7e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—hematologic cancer	1.06e-06	2.66e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—hematologic cancer	1.05e-06	2.64e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—hematologic cancer	1.04e-06	2.61e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—hematologic cancer	1.02e-06	2.56e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3R1—hematologic cancer	9.94e-07	2.5e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—hematologic cancer	9.94e-07	2.5e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—hematologic cancer	9.77e-07	2.46e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—hematologic cancer	9.71e-07	2.44e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—hematologic cancer	9.5e-07	2.39e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—hematologic cancer	9.48e-07	2.38e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—hematologic cancer	9.36e-07	2.35e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—hematologic cancer	9.29e-07	2.34e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—hematologic cancer	9.28e-07	2.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.24e-07	2.32e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—hematologic cancer	9.18e-07	2.31e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—hematologic cancer	8.93e-07	2.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—hematologic cancer	8.85e-07	2.23e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.57e-07	2.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.13e-07	2.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—hematologic cancer	8.02e-07	2.02e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—hematologic cancer	7.93e-07	1.99e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—hematologic cancer	7.76e-07	1.95e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.67e-07	1.93e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—hematologic cancer	7.59e-07	1.91e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—hematologic cancer	7.56e-07	1.9e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.18e-07	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.08e-07	1.78e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.01e-07	1.76e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.6e-07	1.66e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—hematologic cancer	6.55e-07	1.65e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—hematologic cancer	6.12e-07	1.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—hematologic cancer	5.87e-07	1.47e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—hematologic cancer	5.84e-07	1.47e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—hematologic cancer	5.73e-07	1.44e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.6e-07	1.41e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—hematologic cancer	5.4e-07	1.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—hematologic cancer	5.35e-07	1.34e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—hematologic cancer	4.57e-07	1.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.32e-07	1.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—hematologic cancer	3.53e-07	8.87e-06	CbGpPWpGaD
